Trials / Conditions / Recurrent Nasopharyngeal Undifferentiated Carcinoma
Recurrent Nasopharyngeal Undifferentiated Carcinoma
3 registered clinical trials studyying Recurrent Nasopharyngeal Undifferentiated Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Ci NCT04458909 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Cyclophosphamide for Nasopharyngeal Carcinoma NCT02794077 | The University of Hong Kong | Phase 2 |
| Active Not Recruiting | Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or NCT00336063 | National Cancer Institute (NCI) | Phase 1 |